Genpact Limited $G Shares Sold by Greenhaven Associates Inc.

Key Points

• Greenhaven Associates Inc. significantly reduced its stake in Genpact Limited, selling 135,660 shares and retaining only 11,018 shares, representing a 92.5% decrease in holdings during the 2nd quarter.
• Equities analysts have mixed ratings for Genpact, with Mizuho setting a new price target of $51.00 while Needham raised it to $53.00, reflecting differing outlooks on the company's performance.
• Genpact announced a quarterly dividend of $0.17 per share, which will be paid to shareholders on September 25th, representing a yield of 1.6% and a payout ratio of 22.59%.

Greenhaven Associates Inc. cut its holdings in Genpact Limited (NYSE:G - Free Report) by 92.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,018 shares of the business services provider's stock after selling 135,660 shares during the quarter. Genpact makes up approximately 0.0% of Greenhaven Associates Inc.'s portfolio, making the stock its 22nd largest holding. Greenhaven Associates Inc.'s holdings in Genpact were worth $485,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Envestnet Portfolio Solutions Inc. lifted its stake in shares of Genpact by 59.2% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 10,355 shares of the business services provider's stock valued at $522,000 after buying an additional 3,849 shares during the period. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Genpact by 20.6% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 9,650 shares of the business services provider's stock valued at $486,000 after buying an additional 1,651 shares during the period. GAMMA Investing LLC lifted its stake in shares of Genpact by 88.0% during the first quarter. GAMMA Investing LLC now owns 9,744 shares of the business services provider's stock valued at $491,000 after buying an additional 4,561 shares during the period. 111 Capital purchased a new position in shares of Genpact during the fourth quarter valued at approximately $301,000. Finally, Assenagon Asset Management S.A. purchased a new position in shares of Genpact during the first quarter valued at approximately $2,396,000. Hedge funds and other institutional investors own 96.03% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on G shares. Mizuho upped their price objective on shares of Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research note on Tuesday, July 1st. Needham & Company LLC upped their price objective on shares of Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a research note on Friday, August 8th. JPMorgan Chase & Co. reduced their price objective on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 20th. Deutsche Bank Aktiengesellschaft started coverage on shares of Genpact in a research note on Thursday, July 17th. They set a "hold" rating and a $47.00 price target on the stock. Finally, Wall Street Zen downgraded shares of Genpact from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Three equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Genpact has a consensus rating of "Hold" and a consensus target price of $52.29.

Genpact Price Performance

G opened at $42.53 on Monday. The company has a fifty day simple moving average of $44.45 and a 200 day simple moving average of $45.82. The firm has a market cap of $7.41 billion, a price-to-earnings ratio of 14.13, a PEG ratio of 1.46 and a beta of 0.92. Genpact Limited has a twelve month low of $37.82 and a twelve month high of $56.76. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.32.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share for the quarter, beating analysts' consensus estimates of $0.85 by $0.03. The business had revenue of $1.25 billion during the quarter, compared to analyst estimates of $1.23 billion. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The business's revenue was up 6.6% on a year-over-year basis. During the same period last year, the business earned $0.79 EPS. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Equities research analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, September 11th will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.6%. The ex-dividend date of this dividend is Thursday, September 11th. Genpact's dividend payout ratio (DPR) is currently 22.59%.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.